花叶玉簪试管苗快速增殖与移栽

利用花叶玉簪试管苗进行其快速繁殖、壮苗生根与移栽实验,结果表明,在MS基本培养基中附加低浓度6-BA(0.1～0.5 mg/L)和生长素(IBA 0.01 mg/L或NAA 0.1 mg/L)有利于花叶玉簪试管苗离体分株;而附加高浓度6-BA(≥1.0 mg/L)和生长素(IBA 0.01 mg/L或NAA0.1 mg/L)则有利于花叶玉簪愈伤组织分化产生不定芽。MS培养基附加低浓度6-BA(0.1～0.5mg/L)或不加6-BA,配合一定浓度的生长素(IBA 0.1～0.3 mg/L或NAA 0.1 mg/L)有利于花叶玉簪试管苗壮苗生根。生根良好的花叶玉簪试管苗移栽成活率达91%±2%。     

OA对人肝细胞HL-7702和肝癌细胞Bel-7402增殖的影响和对细胞凋亡的诱导作用研究

 以人肝细胞HL-7702和肝癌细胞Bel-7402为研究对象,通过MTT法、细胞外部形态观察、Annexin V.FITC&;PI双染法及TUNEL法等方法,研究了腹泻性贝毒的主要组分大田软海绵酸（Okadaic acid, OA）对其增殖的影响及对细胞凋亡的诱导作用。结果表明：OA对人两株细胞的增殖均有显著的抑制作用,24 h IC₅₀分别为65 ng/mL和60 ng/mL,且这种抑制作用呈剂量依赖性。OA导致两株细胞的形态均发生明显变化：细胞变圆,脱壁,细胞膜形成泡状突起,最终形成膜包裹的凋亡小体。Annexin V.FITC和PI双染法及TUNEL法检测均发现：OA能够诱导两株细胞发生不同程度的凋亡,且凋亡细胞的比例与OA的浓度相关。以上结果表明：OA能够通过抑制细胞增殖和诱导细胞凋亡而对人肝细胞和肝癌细胞造成影响,且这种影响的程度与OA的浓度和作用时间密切相关。     

ROZ与ATRA联合应用对MCF-7细胞诱导作用

研究PPART激动剂罗格列酮（ROZ）与全反式维甲酸（ATRA）联合应用诱导MCF-7细胞发生分化和凋亡的作用,阐述PPARγ激活后的抗肿瘤作用和机制．采用克隆原形成实验测定两化合物对MCF-7细胞存活率的影响;采用诱导分化实验测定两化合物对MCF-7细胞分化的影响;并进一步应用RT—PCR分析两化合物对MCF-7细胞相关基因表达的影响．集落形成实验显示,两化合物联合应用后,能明显抑制MCF-7细胞的生长．诱导分化实验表明,ROZ在低剂量时促进MCF-7细胞的分化,而随着剂量的增加,分化作用减弱,与ATRA联合应用后,同样在低剂量时促进MCF-7细胞分化,并且出现脂滴的细胞数增加,脂滴增大,在高剂量时,分化作用亦有所减弱。RT—PCR结果表明,在两化合物的作用下,MCF-7细胞中PPARγ的表达升高,并使MCF-7细胞中与凋亡相关基因的表达发生变化．ROZ与ATRA联合应用具有协同作用,激活PPARγ,抑制MCF-7细胞增殖,诱导MCF-7细胞发生分化．     

甜菜碱对小鼠脾淋巴细胞的增殖作用

研究甜菜碱对小鼠脾淋巴细胞的增殖作用.应用MTT法观察体外甜菜碱在不同浓度、不同时间对小鼠脾淋巴细胞增殖的影响,应用流式细胞仪（FCM）测小鼠脾淋巴细胞在不同时间周期的变化.结果表明,甜菜碱终浓度0.4、4、20 mmol/L均可促淋巴细胞增值,但终浓度4 mmol/L效果最为明显,在甜菜碱刺激24、48、72 h后,淋巴细胞均可显著增值,但随时间的加倍,增值幅度并不明显,综合考虑,24 h效果更好.终浓度4 mmol/L甜菜碱不同时间均可促进淋巴细胞由G0/G1期进入S期,且作用18 h效果最明显,其G0/G1期由97.03%下降到89.99%,S期由2.58%升高到9.08%.到24 h后,其诱导作用反而有些下降.因此,甜菜碱4 mmol/L作用24 h促淋巴细胞增殖最为理想.4 mmol/L的甜菜碱18 h促进淋巴细胞由G0/G1期进入S期的作用效果最好.     

miR-194-5p通过Wnt5a抑制肝星状细胞活化

为研究miR-194-5p对肝星状细胞(HSCs)活化的影响及作用机制,采用CCK-8、β-半乳糖苷酶染色、Transwell、划痕、集落形成实验和RT-qPCR、Western blot分别检测miR-194-5p对LX-2细胞生物学特性、细胞活化标志物和靶基因表达的影响,并用生物信息学和双荧光素酶报告实验确定miR-194-5p靶基因.结果显示：miR-194-5p抑制LX-2细胞增殖、细胞集落形成、迁移能力以及LX-2细胞中活化标志物的表达,促进LX-2细胞衰老;Wnt5a为miR-194-5p的直接靶基因.研究表明miR-194-5p通过靶定Wnt5a抑制LX-2细胞活化,miR-194-5p和Wnt5a可能是治疗肝纤维化新的靶点.     

A dioestrous increase in thymocyte proliferation during the oestrous cycle

Summary Coitus, which precedes internal fertilisation, is a unique physiological event which allows motile allogeneic spermatozoa to enter the female host and invade her tissues. The cyclic cellular proliferation observed in the thymus of the female rat may be an important preparation of her immune system for this event.     

Autoradiogaphic investigation of cell proliferation in the adrenal cortex of castrated female rats under the influence of oestradiol

Summary Ovariectomy and subsequent treatment with ovarian hormone produces a temporary increase in DNA-synthesizing cells in the zona glomerulosa of the adrenal cortex.     

维生素E和硒对正常及其恶性细胞增殖的联合作用

为进一步评价补充维生素Ｅ和硒的安全性，本文以正常仓鼠幼肾成纤维细细胞株及其多瘤病毒转化的恶性细胞株为对象，探讨了不同浓度的维生素Ｅ和硒对该对细胞增殖情况的单独和联合作用。结果显示：７μｍｏｌ／Ｌ的维生素Ｅ使ＢＨＫ－２１／ｃ１３和ＢＨＫ－２１／ＰｙＹ细胞株在９６ｈ的细胞计数分别增加１１％和１６％；０．１μｍｏｌ／Ｌ的亚硒酸钠对上述二株细胞的增殖无影响；同时补充以上相同浓度的维生素Ｅ和亚硒酸钠，９６ｈ     

TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2

TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in TRAIL-sensitive human malignant glioma cells. We show for the first time that TRAIL stimulates cell growth in TRAIL-resistant glioma cells. TRAIL-induced cell growth in resistant cells occurred through increased cell cycle progression as determined by flow cytometry and Western blot analysis of retinoblastoma protein phosphorylation. Western blot analysis of TRAIL-treated resistant cells revealed phosphorylation of ERK1/2 proteins and in vitro kinase analysis confirmed the activation of the ERK1/2 kinases. Inhibition of MEK1 eliminated both TRAIL-induced ERK1/2 activation and cell proliferation. In addition, siRNA inhibition of c-FLIP expression eliminates TRAIL-induced ERK1/2 activation and proliferation. Furthermore, overexpression of c-FLIP_L potentiates TRAIL-induced ERK1/2 activation and proliferation of resistant glioma cells. Our results have shown for the first time that TRAIL-induced ERK1/2 activation and proliferation of TRAIL-resistant human glioma cells is dependent upon the expression of the long form of the caspase-8 inhibitor c-FLIP_L. Received 2 November 2007; received after revision 14 December 2007; accepted 21 December 2007     

Polycystic kidney diseases: From molecular discoveries to targeted therapeutic strategies

Polycystic kidney diseases (PKDs) represent a large group of progressive renal disorders characterized by the development of renal cysts leading to end-stage renal disease. Enormous strides have been made in understanding the pathogenesis of PKDs and the development of new therapies. Studies of autosomal dominant and recessive polycystic kidney diseases converge on molecular mechanisms of cystogenesis, including ciliary abnormalities and intracellular calcium dysregulation, ultimately leading to increased proliferation, apoptosis and dedifferentiation. Here we review the pathobiology of PKD, highlighting recent progress in elucidating common molecular pathways of cystogenesis. We discuss available models and challenges for therapeutic discovery as well as summarize the results from preclinical experimental treatments targeting key disease-specific pathways. Received 8 August 2007; received after revision 19 September 2007; accepted 2 October 2007